AF
TGTX icon

Amalgamated Financial’s TG Therapeutics TGTX Stock Holding History

Amalgamated Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$201K Buy
+21,120
New +$244K ﹤0.01% 1897

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Amalgamated Financial's TGTX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in TG Therapeutics (TGTX) in Q1 2022: 21,120 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1897 among its holdings.

181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

  • Amalgamated Financial held 21,120 shares of TG Therapeutics worth $201K as of Q1 2022.
  • TG Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • TG Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1897 holding.
  • 181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.